Exane Derivatives’s TESARO, Inc. TSRO Stock Holding History

Exane Derivatives’s Portfolio TSRO Stock Details TSRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,810	Closed	-$134K	–	732
2018 Q4	$134K	Sell	1,810 -900	-33%	-$43.3K	0.02%	290
2018 Q3	$106K	Sell	2,710 -57	-2%	-$2.01K	0.02%	312
2018 Q2	$124K	Buy	2,767 +326	+13%	+$15.8K	0.02%	309
2018 Q1	$141K	Buy	2,441 +499	+26%	+$32.1K	0.03%	258
2017 Q4	$161K	Buy	1,942 +1,123	+137%	+$110K	0.03%	250
2017 Q3	$106K	Buy	+819	New	+$102K	0.02%	249

Other funds holding TSRO

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Exane Derivatives's TSRO Position: Q1 2019 in Review

Exane Derivatives sold out of TESARO, Inc. (TSRO) in Q1 2019, closing a stake of 1,810 shares — an estimated $134K sold.

Exane Derivatives first reported a position in TSRO in Q3 2017 and held it in 6 quarters. The position peaked at $161K in Q4 2017. 2 funds tracked by Wall St. Rank hold TSRO as of Q1 2019.

Exane Derivatives reported no remaining TESARO, Inc. position as of Q1 2019 after selling out during the quarter.
Exane Derivatives sold 1,810 TESARO, Inc. shares in Q1 2019, an estimated $134K.
Exane Derivatives first reported a position in TESARO, Inc. in Q3 2017 and held it in 6 quarters.
Exane Derivatives's TESARO, Inc. position peaked at $161K in Q4 2017.
2 funds tracked by Wall St. Rank held TESARO, Inc. as of Q1 2019.

Based on Exane Derivatives's 13F filing for Q1 2019, filed 24 Apr 2019.